Hemagen Diagnostics Stock Cash Flow From Operations
| HMGNDelisted Stock | USD 0.0001 0.00 0.00% |
Hemagen Diagnostics fundamentals help investors to digest information that contributes to Hemagen Diagnostics' financial success or failures. It also enables traders to predict the movement of Hemagen Pink Sheet. The fundamental analysis module provides a way to measure Hemagen Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hemagen Diagnostics pink sheet.
Hemagen |
Hemagen Diagnostics Company Cash Flow From Operations Analysis
Hemagen Diagnostics' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Hemagen Diagnostics Cash Flow From Operations | (358.69 K) |
Most of Hemagen Diagnostics' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hemagen Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, Hemagen Diagnostics has (358,687) in Cash Flow From Operations. This is 100.07% lower than that of the Health Care Equipment & Supplies sector and 100.57% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 100.04% higher than that of the company.
Hemagen Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hemagen Diagnostics' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Hemagen Diagnostics could also be used in its relative valuation, which is a method of valuing Hemagen Diagnostics by comparing valuation metrics of similar companies.Hemagen Diagnostics is currently under evaluation in cash flow from operations category among its peers.
Hemagen Fundamentals
| Return On Asset | -0.1 | ||||
| Profit Margin | (0.22) % | ||||
| Operating Margin | (0.11) % | ||||
| Current Valuation | 441.76 K | ||||
| Shares Outstanding | 15.5 M | ||||
| Price To Earning | (0.17) X | ||||
| Price To Sales | 0.1 X | ||||
| Revenue | 4.04 M | ||||
| Gross Profit | 1.61 M | ||||
| EBITDA | (273.66 K) | ||||
| Net Income | (907.32 K) | ||||
| Cash And Equivalents | 66.29 K | ||||
| Current Ratio | 1.07 X | ||||
| Book Value Per Share | (0.23) X | ||||
| Cash Flow From Operations | (358.69 K) | ||||
| Earnings Per Share | (0.06) X | ||||
| Number Of Employees | 15 | ||||
| Beta | 0.39 | ||||
| Market Capitalization | 387.51 K | ||||
| Total Asset | 2.44 M | ||||
| Retained Earnings | (26.68 M) | ||||
| Working Capital | 145 K | ||||
| Current Asset | 2.1 M | ||||
| Current Liabilities | 1.95 M | ||||
| Z Score | -13.0 | ||||
| Net Asset | 2.44 M |
About Hemagen Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hemagen Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hemagen Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hemagen Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Hemagen Diagnostics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Hemagen Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hemagen Diagnostics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Hemagen Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hemagen Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hemagen Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hemagen Diagnostics to buy it.
The correlation of Hemagen Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hemagen Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hemagen Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hemagen Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Hemagen Pink Sheet
If you are still planning to invest in Hemagen Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hemagen Diagnostics' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |